BioAge Share Price
NASDAQ: BIOA | Micro Cap | HealthcareBioAge Stock Performance
BioAge Share Price Today
As of 21 November 2026, BioAge Labs, Inc.'s share price is $4.28. The stock opened at $4.60, compared to its previous close of $4.71. During today's trading session, BioAge Labs, Inc.'s share price traded between $4.25 and $4.79, with an average price of $4.52. Over the past 52 weeks, the stock has recorded a high of $25.88 and a low of $4.25. In terms of performance, BioAge Labs, Inc.'s share price has declined by 75.21% over the last six months and is down 54.61% on a year-on-year basis.
BioAge Share Price Chart
BioAge Quarterly Profit & Loss
All figures in USD
BioAge Annual Profit & Loss
All figures in USD
BioAge Balance Sheet
All figures in USD Million
BioAge Cash Flow
All figures in USD Million
About BioAge
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
BioAge Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $5.93 | $4.28 | -27.60% |
Oct 2026 | $7.06 | $5.91 | -16.65% |
Sep 2026 | $9.38 | $7.08 | -29.71% |
Aug 2026 | $9.61 | $10.08 | +11.50% |
Jul 2026 | $24.30 | $9.04 | -63.10% |
Jun 2026 | $17.16 | $24.50 | +41.91% |
May 2026 | $16.63 | $17.27 | +2.83% |
Apr 2026 | $17.91 | $16.79 | -4.03% |
Mar 2026 | $20.10 | $17.50 | -21.34% |
Feb 2026 | $19.73 | $22.24 | +16.90% |
Jan 2026 | $12.70 | $19.02 | +43.97% |
Dec 2025 | $9.14 | $13.21 | +40.14% |